Order Article Reprints

Zussy C, John R, Urgin T, Otaegui L, Vigor C, Acar N, Canet G, Vitalis M, Morin F, Planel E, et al. Intranasal Administration of Nanovectorized Docosahexaenoic Acid (DHA) Improves Cognitive Function in Two Complementary Mouse Models of Alzheimer’s Disease. Antioxidants. 2022; 11(5):838. https://doi.org/10.3390/antiox11050838

Zussy, Charleine, Rijo John, Théo Urgin, Léa Otaegui, Claire Vigor, Niyazi Acar, Geoffrey Canet, Mathieu Vitalis, Françoise Morin, Emmanuel Planel, and et al. 2022. "Intranasal Administration of Nanovectorized Docosahexaenoic Acid (DHA) Improves Cognitive Function in Two Complementary Mouse Models of Alzheimer’s Disease" Antioxidants 11, no. 5: 838. https://doi.org/10.3390/antiox11050838

Zussy, C., John, R., Urgin, T., Otaegui, L., Vigor, C., Acar, N., Canet, G., Vitalis, M., Morin, F., Planel, E., Oger, C., Durand, T., Rajshree, S. L., Givalois, L., Devarajan, P. V., & Desrumaux, C. (2022). Intranasal Administration of Nanovectorized Docosahexaenoic Acid (DHA) Improves Cognitive Function in Two Complementary Mouse Models of Alzheimer’s Disease. Antioxidants, 11(5), 838. https://doi.org/10.3390/antiox11050838